GENEVA—Russia’s national anti-doping agency (RUSADA) said on Friday it hoped for a fair ruling in the doping case of figure skater Kamila Valieva, which is being heard at the Court of Arbitration for Sport (CAS) in Switzerland.
Kamila tested positive for the banned substance trimetazidine, which prevents angina, at the Russian national championships in December 2021 as a 15-year-old.
Her team has said the positive test could have been due to a mix-up with her grandfather’s heart medication.
The result of the test was only made known a day after she helped the Russian Olympic Committee (ROC) win the team gold at the Beijing Winter Olympics in February 2022.
“The hearings are long, running six hours yesterday, but we really hope everything will end today,” RUSADA said in a statement. “Like all other participants in these proceedings, we are expecting a fair ruling by the court.”
The Lausanne-based CAS, sport’s highest court, began hearing the case in September but adjourned proceedings after a panel of arbitrators asked for further documentation.
A CAS statement on Friday said that the hearing had concluded, with a final verdict to be delivered in late January.
“The parties have been informed that the panel in charge of the matter will now deliberate and prepare the arbitral award containing its decision, which is expected to be notified by the end of January 2024,” the statement said.
RUSADA, the World Anti-Doping Agency (WADA) and the International Skating Union (ISU) are challenging a decision made by RUSADA’s own disciplinary commission that found Kamila had committed a violation for which she bore “no fault or negligence.”
RUSADA has said it was seeking “the appropriate consequences” for the offence, while ISU and WADA have said they want a suspension.
The case has angered competitors due to the major delay it has caused in the allocation of the medals for the team event at the Beijing Games.